Market news
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Schrodinger (SDGR), along with New Enterprise Associates and RA Capital Management, established a ne
Nobody agrees on how much oil is actually moving through the Strait of Hormuz right now, not the government, not the satellite trackers, and not the tanker CEOs navigating the chaos. That uncertainty is minting fortunes for some and shutting others out entirely.
AI is reshaping drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci advancing computational platforms and pipelines.
Schrodinger Inc (SDGR) reports robust Q2 2026 with record ACV growth, strategic AI advancements, and raised full-year drug discovery guidance despite margin pressures from hosted transition.
Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Detailed price information for Schrodinger Inc (SDGR-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.